Aspartame
Alternative Names: APM; EQUAL; SC 18862Latest Information Update: 07 Jan 2022
At a glance
- Originator Oklahoma Medical Research Foundation
- Class Dipeptides
- Mechanism of Action Haemoglobin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoarthritis; Pain; Rheumatoid arthritis; Sickle cell anaemia
Most Recent Events
- 04 Apr 2003 No development reported - Clinical-Phase-Unknown for Sickle cell anaemia in USA (PO)
- 04 Apr 2003 No development reported - Preclinical for Osteoarthritis in USA (PO)
- 04 Apr 2003 No development reported - Preclinical for Pain in USA (unspecified route)